Gilead Buys Calistoga Pharma for $375 Milion, Making Move Into Cancer Drugs

Gilead Sciences is the world’s biggest maker of HIV medications, and today it’s making a big move to diversify into the cancer drug field by acquiring Seattle-based Calistoga Pharmaceuticals.
Xconomy